about
Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cellsDC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cellsIdentification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responsesThe tetraspanin protein CD37 regulates IgA responses and anti-fungal immunityImmune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptorsOrganization of the integrin LFA-1 in nanoclusters regulates its activity.Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue.Myofibroblasts in palatal wound healing: prospects for the reduction of wound contraction after cleft palate repair.Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndromeC-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates.Targeting antigens to dendritic cells in vivo.The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells.Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.The European antibody network's practical guide to finding and validating suitable antibodies for research.Aiming to immune elimination of ovarian cancer stem cellsMesenchymal stromal cells: tissue engineers and immune response modulators.Biological mechanisms in palatogenesis and cleft palate.A functional model for adult stem cells in epithelial tissues.Ovarian cancer creates a suppressive microenvironment to escape immune elimination.Hematopoietic stem cells are coordinated by the molecular cues of the endosteal niche.Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections.Harnessing human plasmacytoid dendritic cells as professional APCs.Deciphering the message broadcast by tumor-infiltrating dendritic cells.Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.The multiple faces of prostaglandin E2 G-protein coupled receptor signaling during the dendritic cell life cycle.Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence.Wnt16 is involved in intramembranous ossification and suppresses osteoblast differentiation through the Wnt/β-catenin pathway.Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity.Mesenchymal stem cells respond to TNF but do not produce TNF.Eradicating cancer cells: struggle with a chameleon.In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.An automated multi well cell track system to study leukocyte migration.Analysis of integrin expression in U2OS cells cultured on various calcium phosphate ceramic substrates.Regulation of LFA-1 Expression by CD34 Positive Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments; Subject Heading.Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients.Report on antibodies submitted to the stromal cell section of HLDA8.Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.
P50
Q24298706-F3916841-4704-423E-A84B-4E30A5F9B113Q28138968-E03F8AE9-A14E-4901-AB0B-A19656FC626EQ28616569-793E5FEC-EF4A-455A-83E9-051BE0ED5BEAQ33417649-2DA4C631-45C3-4D02-A55A-10C60BD13CF1Q34619615-3BE5EE24-9964-4F56-85DA-E4EEB64C9AA8Q35128243-437E3662-E617-4E27-B656-84E60F465879Q35887247-FA25C586-27C2-44A4-8F7F-D3F5C75CA11DQ36267733-F1BDC50A-2A0E-4D16-95BB-AF7444DA25C3Q36500599-081AFA0B-366F-4668-9946-E8243551AAA0Q36570320-72744050-55CB-4D25-AF28-D0EB993BEDF9Q36571675-11E35AC1-1D1F-4DC9-A38B-939BDA099225Q36715937-077E4EDC-B478-4CED-A4B7-A56332457C84Q36939901-F632C66B-A596-4ACF-8FE2-D8E60973C425Q37138282-31297EF2-7697-4B63-9D10-C2AC1A76DE5DQ37266548-80A8E3B1-4B86-47BC-941D-B600567ECB6FQ37287391-216A6F9C-494D-4E75-8682-E9B877DEA227Q37364951-02396840-0DE0-4AE9-91D4-A7DF1AFC12BDQ37574137-D37030E1-267F-486E-8B71-36C6C761BF40Q37689997-EA4FD76E-6427-4201-950B-87341B9BAC8BQ37690701-A6080B4C-1AFD-4A55-94D5-250E3506AAF1Q37930287-614D5B72-6ED3-487B-9157-56F9FEB36CF8Q37980404-B989A7BE-39EA-40FF-9480-58DD96D7DC95Q38026363-248BA42D-6CA9-429F-84CD-48FAAC07A96BQ38059499-F4CF6835-7961-4A10-8884-2596AA8504D8Q38093015-D044A91D-F14E-4B1D-88D0-205CF84B409BQ38281546-98C7B976-97BF-49B3-A33B-62BE54F29921Q38366396-DCA487E5-D80A-4C60-91E5-0409BBF67B7DQ39095813-02C378A7-E4A9-45B6-91FD-529DE71CF33AQ39326438-F957FE89-C6A6-4DEA-90FA-CBFF3B3FDBFEQ39777508-C180D846-1671-48D2-875C-DF1EF0002CFFQ40047489-D19B0B60-56C0-4A0E-BF2C-875ECDB78036Q40076581-158C1C92-97A5-4116-A185-2F36EC87D0F2Q40089456-F57477B8-4A72-49D3-8433-DA0BC28498D7Q40634885-42A0DCD9-8E0A-4843-9820-800A49B0F5BFQ40796073-84E62929-BE00-4E2D-8BBA-18E50A904639Q40799492-468E8B7C-15B4-462E-AA0C-AA57450C9879Q41220323-3F4E6B0F-2E4A-4D85-A20A-87D27A91892DQ41856443-6423BE77-C0B4-4A89-9F29-4F4B11D7D1D4Q41933827-0EADBA1C-6975-4FC5-A8B0-F49AE2550706Q42017071-BE31D3C1-62B3-49A8-9A10-AD5795E4308F
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ruurd Torensma
@ast
Ruurd Torensma
@en
Ruurd Torensma
@es
Ruurd Torensma
@nl
Ruurd Torensma
@sl
type
label
Ruurd Torensma
@ast
Ruurd Torensma
@en
Ruurd Torensma
@es
Ruurd Torensma
@nl
Ruurd Torensma
@sl
prefLabel
Ruurd Torensma
@ast
Ruurd Torensma
@en
Ruurd Torensma
@es
Ruurd Torensma
@nl
Ruurd Torensma
@sl
P214
P1053
C-2853-2009
P106
P21
P214
P31
P3829
P496
0000-0002-0555-7903
P7859
viaf-315216200